Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AOC3 | Q16853 | 2/20 | 0.54 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | CASR | P41180 | 1/20 | 0.51 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.50 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.50 |
| ▸ | BRD4 | O60885 | 2/20 | 0.49 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.49 |
| ▸ | CA4 | P22748 | 1/20 | 0.48 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.48 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.48 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.48 |
| ▸ | CNR2 | P34972 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27686957 | 1.00 | AOC3 (0.54) | AOC3L3MBTL1CASRPKMMTNR1A | |
| SCHEMBL2093768 | 0.94 | AOC3 (0.59) | AOC3L3MBTL1CASRPKMBRD4 | |
| Acetic Acid SCHEMBL28094254 | 0.93 | MTNR1A (0.56) | AOC3L3MBTL1MTNR1AMTNR1B | |
| SCHEMBL4822561 | 0.89 | AOC3 (0.54) | AOC3L3MBTL1PKMBRD4CREBBP | |
| SCHEMBL3470936 | 0.87 | AOC3 (0.50) | AOC3L3MBTL1CASRPKMMTNR1A | |
| SCHEMBL4819668 | 0.86 | BRD4 (0.57) | AOC3L3MBTL1CASRBRD4CREBBP | |
| SCHEMBL23882846 | 0.86 | ROCK1 (0.50) | AOC3L3MBTL1PKMBRD4 | |
| SCHEMBL9438783 | 0.86 | LMNA (0.49) | AOC3L3MBTL1CASRPKMBRD4 | |
| SCHEMBL6598474 | 0.86 | IGF1R (0.50) | AOC3L3MBTL1PKMBRD4CHRM2 | |
| SCHEMBL6791737 | 0.86 | MTNR1A (0.56) | AOC3L3MBTL1PKMMTNR1AMTNR1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3688000-B1 | HYDROCARBON-SOLUBLE HALOGEN AND THIOLATE/MAGNESIUM EXCHANGE REAGENTS | ALBEMARLE GERMANY GMBH (DE) | 2023-11-08 | — | — | EP | disclosed |
| US-11236113-B2 | Hydrocarbon-soluble halogen and thiolate/magnesium exchange reagents | ALBEMARLE GERMANY GMBH (DE) | 2022-02-01 | — | — | US | disclosed |
| EP-3109703-B1 | PHOTOSENSITIZATION CHEMICAL-AMPLIFICATION TYPE RESIST MATERIAL, AND METHOD FOR FORMING PATTERN USING SAME | TOKYO ELECTRON LTD (JP) | 2020-12-30 | — | — | EP | disclosed |
| US-20200239496-A1 | Hydrocarbon-Soluble Halogen and Thiolate/Magnesium Exchange Reagents | Ludwig-Maximilians-Universitat München (DE) | 2020-07-30 | — | — | US | disclosed |
| CN-109053754-B | Synthetic method for constructing polysubstituted chroman compound based on biomass source 2, 5-dimethylfuran dearomatization cycloaddition strategy | 青岛农业大学 | 2020-04-07 | — | — | CN | disclosed |
| WO-2019063418-A1 | HYDROCARBON-SOLUBLE HALOGEN AND THIOLATE/MAGNESIUM EXCHANGE REAGENTS | ALBEMARLE GERMANY GMBH (DE) | 2019-04-04 | — | — | WO | disclosed |
| US-10025187-B2 | Photosensitization chemical-amplification type resist material, method for forming pattern using same, semiconductor device, mask for lithography, and template for nanoimprinting | TOKYO ELECTRON LIMITED (JP) | 2018-07-17 | — | — | US | disclosed |
| US-10018911-B2 | Chemically amplified resist material and resist pattern-forming method | JSR CORPORATION (JP) | 2018-07-10 | — | — | US | disclosed |
| US-10018911-B2 | Chemically amplified resist material and resist pattern-forming method | JSR CORPORATION (JP) | 2018-07-10 | — | — | US | disclosed |
| US-9971247-B2 | Pattern-forming method | OSAKA UNIVERSITY (JP) | 2018-05-15 | — | — | US | disclosed |
| EP-2810072-A1 | COMPOSITIONS AND METHODS FOR DETECTION OF METHODONE METABOLITE | Siemens Healthcare Diagnostics Inc. (US) | 2014-12-10 | — | — | EP | disclosed |
| US-20140221626-A1 | COMPOSITIONS AND METHODS FOR DETECTION OF METHADONE METABOLITE | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2014-08-07 | — | — | US | disclosed |
| US-8771964-B2 | Compositions and methods for detection of methadone metabolite | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2014-07-08 | — | — | US | disclosed |
| US-8563786-B2 | Method for producing optically active alcohol | MITSUI CHEMICALS, INC. (JP) | 2013-10-22 | — | — | US | disclosed |
| US-20130203076-A1 | COMPOSITIONS AND METHODS FOR DETECTION OF METHADONE METABOLITE | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2013-08-08 | — | — | US | disclosed |
| WO-2013116088-A1 | COMPOSITIONS AND METHODS FOR DETECTION OF METHODONE METABOLITE | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2013-08-08 | — | — | WO | disclosed |
| US-20120088938-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2012-04-12 | — | — | US | disclosed |
| EP-2412694-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | Mitsui Chemicals, Inc. (JP) | 2012-02-01 | — | — | EP | disclosed |
| US-5236952-A | Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa | HOFFMANN-LA ROCHE INC. (US) | 1993-08-17 | — | — | US | disclosed |
| US-4138488-A | Diphenylmethyl picolinic acid derivatives and their use as anti-acne agents | SCHERING CORPORATION (US) | 1979-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10025187-B2 | Photosensitization chemical-amplification type resist material, method for forming pattern using same, semiconductor device, mask for lithography, and template for nanoimprinting | ASIC1, ASIC3, CLTA | AOC3 4095/4885L3MBTL1 3448/4885CASR 120/4885 |
| US-20140221626-A1 | COMPOSITIONS AND METHODS FOR DETECTION OF METHADONE METABOLITE | DNPEP, OPRD1, NPEPPS | AOC3 2715/4885L3MBTL1 415/4885CASR 4463/4885 |
| US-20200239496-A1 | Hydrocarbon-Soluble Halogen and Thiolate/Magnesium Exchange Reagents | OR10J3, MSRB3, SLC39A3 | AOC3 44/4885L3MBTL1 2069/4885CASR 617/4885 |
| US-20130203076-A1 | COMPOSITIONS AND METHODS FOR DETECTION OF METHADONE METABOLITE | DNPEP, OPRD1, NPEPPS | AOC3 2715/4885L3MBTL1 415/4885CASR 4463/4885 |
| US-20120088938-A1 | METHOD FOR PRODUCING OPTICALLY ACTIVE ALCOHOL | ADH1A, ADH1C, FHIT | AOC3 246/4885L3MBTL1 4093/4885CASR 4058/4885 |
| US-10018911-B2 | Chemically amplified resist material and resist pattern-forming method | SLC11A2, XRCC5, RAD54L | AOC3 3396/4885L3MBTL1 4063/4885CASR 46/4885 |
| US-11236113-B2 | Hydrocarbon-soluble halogen and thiolate/magnesium exchange reagents | MSRB3, OR10J3, GFER | AOC3 67/4885L3MBTL1 1701/4885CASR 499/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.